MediView XR, Inc.
MediView XR, Inc. is a Cleveland, Ohio-based med-tech company pioneering the use of augmented reality (AR) and mixed reality to transform medical imaging, surgical navigation, and patient care. Their mission is to advance healthcare delivery with intuitive visualization, seamless collaboration, and evidence-based insights. MediView’s vision is to simplify, democratize, and inform healthcare delivery by unlocking the full potential of 3D data for image-guided procedures. Through partnerships with leading organizations such as GE HealthCare, Mayo Clinic, and Microsoft, MediView delivers AR-powered visualization and navigation solutions that provide clinicians with unprecedented 3D "X-ray vision," real-time collaboration, and improved procedural accuracy. The company is recognized for its innovative approach to addressing health equity by expanding access to advanced care, especially in rural and underserved communities. MediView’s technology is also making significant strides in medical education, enabling immersive, hands-on learning and remote collaboration for students and clinicians.
MediView XR, Inc.
Global Innovation Center, 10000 Cedar Ave. Suite GCIC2-153, Cleveland, Ohio 44106
What We Do
An interventional augmented-reality solution that fits seamlessly into existing interventional suites, supporting workflow efficiency, improved visualization, and collaborative care through AR technology.
A first-in-class AR visualization and navigation system for minimally invasive, needle-based, ultrasound-guided soft tissue and bone procedures. Provides 3D views of patient anatomy, displaying organs, vasculature, and bone with depth and detail.
An AR solution in early commercialization that addresses ergonomic challenges in medical imaging, allowing practitioners to optimally position ultrasound imaging in their line of sight and collaborate with remote caregivers.
An AR platform to be submitted for FDA clearance, adding procedural guidance capabilities to the XR30 by creating a visible pathway for the practitioner’s instrument during procedures.
A technology incorporated into academic programs, such as the University of Findlay’s Sonography Program, enabling hands-on AR-based learning for sonography and medical imaging.
MediView provides an intuitive AR visualization platform that enables clinicians to perform image-guided medical procedures with 3D X-ray vision, real-time collaboration, and evidence-based data insights.
Application Area
Show LessRegenerative Medicine
Diagnostics
Key People
Chief Executive Officer & President
Chief Business Development Officer, Cofounder & Chairman
Chief Technology Officer
Chief Information & Security Officer
VP of Human Resources
VP of Commercialization and Customer Success
News & Updates
MediView XR was announced as the grand prize winner of the 2022 CableLabs 10G Challenge, recognizing its efforts in improving access to specialized breast cancer care with telehealth innovation.
Received 510(k) clearance from the U.S. Food and Drug Administration for the XR90 AR-based surgical visualization and navigation platform.
First worldwide clinical case using the FDA-cleared XR90 AR-based surgical visualization and navigation system performed at NewYork-Presbyterian Hospital / Weill Cornell Medicine.
GE HealthCare and MediView announced the world’s first installation and clinical use of the OmnifyXR Interventional Suite at North Star Vascular and Interventional in Minneapolis, Minnesota.
Secured $15M in strategic funding from leading collaborators across clinical, industry, and government sectors.
MediView took top honors in the Medical Capital Innovation Competition, recognizing its leadership in medical AR innovation.
Carle Illinois College of Medicine became the first in the world to use MediView XR's FDA-cleared hologram technology for patient treatment.
Discusses the use of AR for real-time image guidance in cryoneurolysis, highlighting the potential for improved navigation and outcomes in interventional radiology.
A review of AR's potential in enhancing surgical navigation for percutaneous tumor ablation, focusing on advanced needle guidance systems.
A review of current AR/VR applications in interventional radiology, with a focus on clinical impact, limitations, and future directions, including the first clinical use of XR90.
Highlights the University of Findlay's integration of MediView's MediScout technology into its Sonography Program, providing students with hands-on AR-based learning.
Carle Illinois College of Medicine is the first in the world to use MediView XR's FDA-cleared hologram technology for patient treatment.
MediView XR, Inc. announced the closing of a $9.9MM round of SAFE financing to support technology development, commercialization, and regulatory submissions.
Forbes article covering MediView XR's $9.9M funding round for its AR surgical navigation platform, enabling intraoperative 3D 'x-ray' holographic visualization.
Wired article discussing the entry of mixed reality displays into the operating room, featuring MediView's HoloLens-based technology for surgical planning and real-time guidance.
MediView AR won first place at the AAMI Exchange Xcelerator pitch competition, earning $10,000 for its 'X-ray vision' technology that superimposes 3D holograms of patient anatomy in real time for improved cancer treatment.
A study published in the Journal of Medical Imaging evaluates MediView's AR platform for minimally invasive percutaneous procedures, highlighting its potential to overcome the limitations of 2D imaging.
This article discusses the integration of AR with ultrasound equipment, marking a new generation of imaging designed with an ergonomic focus.
MediView took top honors in the Medical Capital Innovation Competition, highlighting its leadership in medical AR innovation.
Explores the use of AR to improve preoperative evaluation of disease burden in ovarian cancer.
Announces the world's first 5-patient in-human evaluation of AR-guided tumor ablation completed at the Cleveland Clinic.
Reports the world's first-in-human augmented reality tumor ablation completed at the Cleveland Clinic using MediView's technology.
Dr. Alexander Misono joins MediView's Clinical Advisory Board, bringing expertise in interventional radiology.
Dr. Francois Cornelis joins the Clinical Advisory Board, contributing his experience from Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine.
Dr. Jordan Tasse, Director of Interventional Oncology at Rush University Medical Center, joins the Clinical Advisory Board.
Study results published in the Journal of Medical Imaging demonstrate the high accuracy of MediView's XR90 AR-based surgical visualization and navigation system.
Carle Illinois College of Medicine partners with MediView to integrate AR-based hologram systems into education, innovation, and clinical programs.
Karley Yoder, General Manager & Chief Digital Officer for GE Healthcare's global ultrasound business, joins MediView's Board of Directors.
MediView receives FDA 510(k) clearance for its XR90 AR-based surgical visualization and navigation platform, intended for minimally invasive ultrasound and CT guided needle-based procedures.
MediView secures $15M in strategic funding from Mayo Clinic, Cleveland Clinic, GE HealthCare, JobsOhio Capital Growth Fund, and others.
GE HealthCare and MediView announce the first installation and clinical use of the OmnifyXR Interventional Suite at North Star Vascular and Interventional in Minneapolis, Minnesota.
First inpatient utilization of XR90 AR-based surgical visualization and navigation system since FDA 510(k) clearance, performed at NewYork-Presbyterian Hospital / Weill Cornell Medicine.
MediView participated in the SCSP AI Expo in Washington D.C., June 2-4, 2025.
MediView attended the AR/VR Policy Conference in Washington D.C., September 8, 2025.
MediView was present at the Western Angiographic & Interventional Society (WAIS) event in Colorado Springs, September 20-24, 2025.